Zobrazeno 1 - 10
of 179
pro vyhledávání: '"Niraj J Gusani"'
Autor:
Udhayvir Singh Grewal, Arjun Gupta, Jamie Doggett, Emil Lou, Niraj J Gusani, Anirban Maitra, Muhammad Shaalan Beg, Allyson J Ocean
Publikováno v:
JMIR Cancer, Vol 8, Iss 1, p e31388 (2022)
Background There is a growing interest in the pattern of consumption of health-related information on social media platforms. ObjectiveWe evaluated the content of discussions around pancreatic cancer on Twitter to identify subtopics of greatest inte
Externí odkaz:
https://doaj.org/article/a6db031ee1794281ae62367933fd826c
Publikováno v:
Therapeutics and Clinical Risk Management, Vol 2010, Iss default, Pp 453-458 (2010)
Isabelle Deshaies1, Jovenel Cherenfant1, Niraj J Gusani1, Yixing Jiang2, Harold A Harvey2, Eric T Kimchi1, Jussuf T Kaifi1, Kevin F Staveley-O’Carroll11Program for Liver, Pancreas and Foregut Tumors, Department of Surgery, Penn State College of Med
Externí odkaz:
https://doaj.org/article/e535afb13d4a492a9d6b63e63213d671
Publikováno v:
Journal of Pancreatic Cancer. 8:15-24
Background: The impact of do-not-resuscitate (DNR) order on patients with pancreatic cancer remains uncertain. In this study, we evaluated whether DNR status was associated with in-hospital mortality and costs for the inpatient stay among patients ho
Autor:
Elizabeth J. Olecki, Mackenzie M. Mayhew, Rolfy Perez-Holguin, William G. Wong, Kelly A. Stahl, June S. Peng, Matthew E. Dixon, Niraj J. Gusani
Purpose: Risk factors of Gallbladder Cancer (GBC) are not well-defined resulting in greater than 60% of GBCs being diagnosed incidentally following cholecystectomy performed for presumed benign indications. As most localized GBC require more extensiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::683ad4ef734e6f0414b16cd47bf035e4
https://doi.org/10.21203/rs.3.rs-2532001/v1
https://doi.org/10.21203/rs.3.rs-2532001/v1
Autor:
Jennifer L. Maranki, Niraj J. Gusani, Charles Dye, Heather D. Heisey, Abraham Mathew, Kayla M. Hartz, Leonard Walsh, Courtney Lester, Brandy D. Headlee, John M. Levenick, Matthew E.B. Dixon, Matthew T. Moyer, James H. Birkholz
Publikováno v:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Pancreatic cancer has known precursor lesions with potential to develop into malignancy over time. At least 20% of pancreatic cancer evolves from mucinous cystic neoplasms and intraductal papillary mucinous neoplasms, which are often discovered incid
Publikováno v:
Surgical Oncology Clinics of North America. 31:43-54
Pancreatic cancer is the third leading cause of cancer deaths in the United States. Black patients with pancreatic cancer experience higher incidence and increased mortality. Although racial biologic differences exist, socioeconomic status, insurance
Autor:
Chan Shen, June S. Peng, Kelly A. Stahl, Matthew E.B. Dixon, Niraj J. Gusani, Madeline B. Torres, Elizabeth J. Olecki
Publikováno v:
Current Oncology, Vol 28, Iss 17, Pp 138-151 (2021)
Current Oncology
Volume 28
Issue 1
Pages 17-151
Current Oncology
Volume 28
Issue 1
Pages 17-151
Gastric cancer is the third most common cause of cancer deaths worldwide. Despite evidence-based recommendation for treatment, the current treatment patterns for all stages of gastric cancer remain largely unexplored. This study investigates trends i
Autor:
Ming Wang, Brianna M. Jones, Kelsey C. Stoltzfus, Alexander V. Louie, Shankar Siva, Vonn Walter, Niraj J Gusani, Nicholas G. Zaorsky, Daniel M. Trifiletti, Eric J. Lehrer
Publikováno v:
American Journal of Clinical Oncology. 44:572-579
OBJECTIVES: Metastatic cancer has historically been considered fatal; however, there is a paucity of evidence characterizing the epidemiology of incidence, treatment, and outcomes in these patients. MATERIALS AND METHODS: Incidence rates, annual perc
Autor:
Leila T. Tchelebi, Biyi Shen, Daniel M. Trifiletti, Vonn Walter, Nicholas G. Zaorsky, Kelsey C. Stoltzfus, Niraj J. Gusani, Ming Wang
Publikováno v:
Journal of the National Comprehensive Cancer Network. 19:495-503
Background: Increased facility surgical treatment volume is sometimes associated with improved survival in patients with cancer; however, published studies evaluating volume are heterogeneous and disparate in their patient inclusion and definition of
Autor:
June S. Peng, Matthew E.B. Dixon, Chan Shen, Kelly A. Stahl, Elizabeth J. Olecki, Madeline B. Torres, Niraj J. Gusani
Publikováno v:
Journal of Surgical Oncology. 124:79-87
BACKGROUND Clinical and pathologic staging determine treatment of pancreatic cancer. Clinical stage has been shown to underestimate final pathologic stage in pancreatic cancer, resulting in upstaging. METHODS National Cancer Database was used to iden